Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

The search for effective drug treatments for COVID-19

The search for effective drug treatments for COVID-19

They were coordinated by the China-Japan Friendship Hospital in Beijing. The results from the severe study was published in The Lancet.

Roche’s flu pill Xofluza gains EU approval

Roche’s flu pill Xofluza gains EU approval Xofluza was originally discovered and developed by Japanese pharma company Shionogi, which retains the rights to Xofluza in Japan and Taiwan, while Roche holds the remaining worldwide rights to the drug.

AZ divests European rights for cholesterol med Crestor to Grünenthal

AZ divests European rights for cholesterol med Crestor to Grünenthal AZ will continue to sell the drug in countries not included in the agreement, including North America, Japan and China.

Biogen signs $3.1bn deal with Sage for potential depression therapies

Biogen signs $3.1bn deal with Sage for potential depression therapies Outside the US, Biogen will hold responsibility for development and commercialisation with respect to zuranolone, excluding Japan, Taiwan and South Korea.

BMS’ Opdivo wins EU approval for second-line oesophageal cancer

BMS’ Opdivo wins EU approval for second-line oesophageal cancer Opdivo (nivolumab) first gained approval in this setting in February, after Japan’s Ministry of Health, Labour and Welfare (MHLW) approved the checkpoint inhibitor for unresectable advanced, or recurrent oesophageal cancer

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics